We just received data on a new analyst forecast for $T. Wells Fargo gave a rating of 'Overweight' for $T.
$T Analyst Ratings
Wall Street analysts have issued reports on $T in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 10/16/2025
- Raymond James issued a "Strong Buy" rating on 09/18/2025
- Bernstein issued a "Outperform" rating on 09/04/2025
- Goldman Sachs issued a "Buy" rating on 09/02/2025
- JP Morgan issued a "Overweight" rating on 07/24/2025
- Morgan Stanley issued a "Overweight" rating on 07/16/2025
- UBS issued a "Buy" rating on 06/18/2025
To track analyst ratings and price targets for $T, check out Quiver Quantitative's $T forecast page.
$T Price Targets
Multiple analysts have issued price targets for $T recently. We have seen 16 analysts offer price targets for $T in the last 6 months, with a median target of $31.0.
Here are some recent targets:
- Eric Luebchow from Wells Fargo set a target price of $29.0 on 10/16/2025
- Kannan Venkateshwar from Barclays set a target price of $30.0 on 10/01/2025
- Frank Louthan from Raymond James set a target price of $33.0 on 09/18/2025
- Laurent Yoon from Bernstein set a target price of $32.0 on 09/04/2025
- Michael Ng from Goldman Sachs set a target price of $32.0 on 09/02/2025
- Sebastiano Petti from JP Morgan set a target price of $33.0 on 07/24/2025
- Simon Flannery from Morgan Stanley set a target price of $32.0 on 07/16/2025
$T Congressional Stock Trading
Members of Congress have traded $T stock 8 times in the past 6 months. Of those trades, 4 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $T stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 2 purchases worth up to $30,000 on 07/18 and 0 sales.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/17 and 1 sale worth up to $15,000 on 07/10.
- REPRESENTATIVE JAMES COMER sold up to $15,000 on 07/03.
- REPRESENTATIVE CLEO FIELDS purchased up to $50,000 on 06/30.
- REPRESENTATIVE J. FRENCH HILL sold up to $15,000 on 06/23.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$T Insider Trading Activity
$T insiders have traded $T stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $T stock by insiders over the last 6 months:
- SANDERS S SABRINA (SVP-ChiefActngOfcr&Controller) sold 1,500 shares for an estimated $41,347
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$T Hedge Fund Activity
We have seen 1,423 institutional investors add shares of $T stock to their portfolio, and 1,243 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 181,988,858 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $5,139,365,349
- CAPITAL RESEARCH GLOBAL INVESTORS added 41,958,911 shares (+180.2%) to their portfolio in Q2 2025, for an estimated $1,214,290,884
- FMR LLC removed 28,459,633 shares (-38.7%) from their portfolio in Q2 2025, for an estimated $823,621,779
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 18,239,466 shares (-54.7%) from their portfolio in Q2 2025, for an estimated $527,850,146
- CAPITAL WORLD INVESTORS removed 12,987,869 shares (-22.3%) from their portfolio in Q2 2025, for an estimated $375,868,928
- VANGUARD GROUP INC added 10,310,560 shares (+1.6%) to their portfolio in Q2 2025, for an estimated $298,387,606
- POINT72 ASSET MANAGEMENT, L.P. added 8,269,927 shares (+4633.5%) to their portfolio in Q2 2025, for an estimated $239,331,687
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
